Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 226 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 to 75				Other				ADO-MM-PAL8 NCT00226473


2.		A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Natural history/Epidemiology, Treatment				Active				16 and over				Pharmaceutical / Industry				CA184-025 NCT00162123

Last Modified: 10/8/2008 First Published: 12/1/1998


3.		Phase III Randomized Adjuvant Study of High-Dose Interferon alfa-2b Therapy in Patients With Stage II or III Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				ECOG-1697 SWOG-E1697, CALGB-500103, CAN-NCIC-ME10, COG-E1697, E1697, NCT00003641, ME10

Last Modified: 6/11/2008 First Published: 6/1/1999


4.		Phase III Randomized Study of High-Dose Aldesleukin With or Without gp100 Antigen in Patients With Locally Advanced or Metastatic Cutaneous Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				CCCGHS-NCI-T98-0085 NCI-T98-0085, NCI-99-C-0051B, T98-0085, NCT00019682


5.		A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				11718 NCT00111007


6.		Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 70				Other				MM-ADJ-5 NCT00226408


7.		PegIntron vs IntronA in CMAJCC Stage II (EADO 2001/CMII Trial).

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 75				Other				9267-01 2001-034, NCT00221702


8.		Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				05 DIVE 03 NCT00224744


9.		Tumor Infiltrating Lymphocytes Adjuvant Therapy of Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 75				Other				BRD/04/1-D NCT00200577


10.		Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				TROG 02.01 NHMRC 251732, NCT00287196

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute